An Integrative Network Approach for Genomic Discovery and Personalized Therapy in Relapsed Multiple Myeloma

被引：0
|
作者：
Readhead, Ben [1 ]
Kania, Krishan [2 ]
Eden, Caroline [3 ]
Perumal, Deepak [1 ]
Gidwani, Vickram [3 ]
Chari, Ajai [4 ,5 ]
Cho, Hearn Jay [1 ]
Jagannath, Sundar [6 ]
Kuo, Pei-Yu [1 ]
Kidd, Brian [4 ]
Dudley, Joel [1 ]
Parekh, Samir [3 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Princeton Univ, Princeton, NJ 08544 USA
[3] Mt Sinai Hosp, New York, NY 10029 USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA
[6] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Carfilzomib Triple Combination Therapy: A Review in Relapsed Multiple Myeloma
    Sheridan M. Hoy
    Targeted Oncology, 2016, 11 : 255 - 262
  • [42] Choosing optimal therapy for relapsed refractory multiple myeloma: A systematic review and network meta-analysis.
    Nadeem, Mahum
    Gupta, Samiksha
    Naqvi, Syed Arsalan Ahmed
    Bin Riaz, Irbaz
    Chakraborty, Rajshekhar
    Aljama, Mohammed A.
    Husnain, Muhammad
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma
    Ziccheddu, Bachisio
    Biancon, Giulia
    Bagnoli, Filippo
    De Philippis, Chiara
    Maura, Francesco
    Rustad, Even H.
    Dugo, Matteo
    Devecchi, Andrea
    De Cecco, Loris
    Sensi, Marialuisa
    Terragna, Carolina
    Martello, Marina
    Bagratuni, Tina
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    Cavo, Michele
    Carniti, Cristiana
    Montefusco, Vittorio
    Corradini, Paolo
    Bolli, Niccolo
    BLOOD ADVANCES, 2020, 4 (05) : 830 - 844
  • [44] Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
    Dingli, David
    Ailawadhi, Sikander
    Bergsagel, P. Leif
    Buadi, Francis K.
    Dispenzieri, Angela
    Fonseca, Rafael
    Gertz, Morie A.
    Gonsalves, Wilson I.
    Hayman, Susan R.
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Kumar, Shaji K.
    Kyle, Robert A.
    Lacy, Martha Q.
    Leung, Nelson
    Lin, Yi
    Lust, John A.
    Mikhael, Joseph R.
    Reeder, Craig B.
    Roy, Vivek
    Russell, Stephen J.
    Sher, Taimur
    Stewart, A. Keith
    Warsame, Rahma
    Zeldenrust, Stephen R.
    Rajkumar, S. Vincent
    Khan, Asher A. Chanan
    MAYO CLINIC PROCEEDINGS, 2017, 92 (04) : 578 - 598
  • [45] High-Throughput Functional Drug Screening and Genomic Analysis to Guide Individualized Therapy for Relapsed/Refractory Multiple Myeloma
    Coffey, David G.
    Cowan, Andrew J.
    Martins, Timothy S.
    Green, Damian J.
    Libby, Edward N., III
    Silbermann, Rebecca W.
    Chien, Sylvia
    Dai, Jin
    Morales, Alicia
    Curley, Niall
    Degraaff, Bret Gary
    Gooley, Ted A.
    Warren, Edus H.
    Becker, Pamela S.
    BLOOD, 2019, 134
  • [46] Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines
    Lionetti, Marta
    Agnelli, Luca
    Mosca, Laura
    Todoerti, Katia
    Ronchetti, Domenica
    Fabris, Sonia
    Andronache, Adrian
    Verdelli, Donata
    Ponzo, Paola
    Deliliers, Giorgio Lambertenghi
    Neri, Antonino
    BLOOD, 2008, 112 (11) : 595 - 595
  • [47] INTEGRATIVE GENOMIC APPROACH IDENTIFIES DEREGULATED MICRORNAS IN HUMAN MYELOMA CELL LINES
    Lionetti, M.
    Agnelli, L.
    Mosca, L.
    Ronchetti, D.
    Fabris, S.
    Andronache, A.
    Todoerti, K.
    Verdelli, D.
    Ponzo, P.
    Bicciato, S.
    Deliliers, Lambertenghi G.
    Neri, A.
    HAEMATOLOGICA, 2008, 93 : S108 - S108
  • [48] Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma
    Chari, Ajai
    Larson, Sarah
    Holkova, Beata
    Cornell, Robert F.
    Gasparetto, Cristina
    Karanes, Chatchada
    Matous, Jeffrey V.
    Niesvizky, Ruben
    Valent, Jason
    Lunning, Matthew
    Usmani, Saad Z.
    Anderson, Larry D., Jr.
    Chang, Lipo
    Lee, Yihua
    Pak, Yvonne
    Salman, Zeena
    Graef, Thorsten
    Bilotti, Elizabeth
    Chhabra, Saurabh
    LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2588 - 2594
  • [49] A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
    Richardson, Paul G.
    Blood, Emily
    Mitsiades, Constantine S.
    Jagannath, Sundar
    Zeldenrust, Steven R.
    Alsina, Melissa
    Schlossman, Robert L.
    Rajkumar, S. Vincent
    Desikan, K. Raman
    Hideshima, Teru
    Munshi, Nikhil C.
    Kelly-Colson, Kathleen
    Doss, Deborah
    McKenney, Mary L.
    Gorelik, Svetlana
    Warren, Diane
    Freeman, Andrea
    Rich, Rebecca
    Wu, Anfang
    Olesnyckyj, Marta
    Wride, Kenton
    Dalton, William S.
    Zeldis, Jerome
    Knight, Robert
    Weller, Edie
    Anderson, Kenneth C.
    BLOOD, 2006, 108 (10) : 3458 - 3464
  • [50] KD-PACE salvage therapy for aggressive relapsed multiple myeloma
    Harrell, Shelton
    Khan, Muhammad
    Dhakal, Binod
    Parameswaran, Hari
    Cornell, Robert
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E252 - E253
12345